These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19588916)

  • 21. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.
    Knights AJ; Fucikova J; Pasam A; Koernig S; Cebon J
    Cancer Immunol Immunother; 2013 Feb; 62(2):321-35. PubMed ID: 22923192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.
    Wright CW; Duckett CS
    J Clin Invest; 2005 Oct; 115(10):2673-8. PubMed ID: 16200201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.
    Dean EJ; Ranson M; Blackhall F; Holt SV; Dive C
    Cancer Treat Rev; 2007 Apr; 33(2):203-12. PubMed ID: 17210228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
    Li QX; Yu DH; Liu G; Ke N; McKelvy J; Wong-Staal F
    Cell Death Differ; 2008 Aug; 15(8):1197-210. PubMed ID: 18437165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathways: targeting death receptors and smac mimetics.
    Fulda S
    Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting survivin in cancer: the cell-signalling perspective.
    Kanwar JR; Kamalapuram SK; Kanwar RK
    Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
    Vucic D
    Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting IAP proteins in combination with radiotherapy.
    Fulda S
    Radiat Oncol; 2015 Apr; 10():105. PubMed ID: 25927408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold.
    Cohen F; Alicke B; Elliott LO; Flygare JA; Goncharov T; Keteltas SF; Franklin MC; Frankovitz S; Stephan JP; Tsui V; Vucic D; Wong H; Fairbrother WJ
    J Med Chem; 2009 Mar; 52(6):1723-30. PubMed ID: 19228017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cell migration, invasion and metastasis by IAP proteins and their antagonists.
    Fulda S
    Oncogene; 2014 Feb; 33(6):671-6. PubMed ID: 23474760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IAP-targeted therapies for cancer.
    LaCasse EC; Mahoney DJ; Cheung HH; Plenchette S; Baird S; Korneluk RG
    Oncogene; 2008 Oct; 27(48):6252-75. PubMed ID: 18931692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of apoptosis: clinical implications in cancer.
    Mohamed MS; Bishr MK; Almutairi FM; Ali AG
    Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smac mimetics as new cancer therapeutics.
    Chen DJ; Huerta S
    Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres.
    Cohen F; Koehler MF; Bergeron P; Elliott LO; Flygare JA; Franklin MC; Gazzard L; Keteltas SF; Lau K; Ly CQ; Tsui V; Fairbrother WJ
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2229-33. PubMed ID: 20189383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Multiple Roles of the IAP Super-family in cancer.
    Kumar S; Fairmichael C; Longley DB; Turkington RC
    Pharmacol Ther; 2020 Oct; 214():107610. PubMed ID: 32585232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-3256336, a novel and orally available small molecule IAP antagonist, induced tumor cell death via induction of systemic TNF alpha production.
    Sumi H; Inazuka M; Hashimoto K; Ishikawa T; Yoshida S; Yabuki M
    Biochem Biophys Res Commun; 2016 Oct; 479(2):179-185. PubMed ID: 27608596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-protein interactions and cancer: small molecules going in for the kill.
    Arkin M
    Curr Opin Chem Biol; 2005 Jun; 9(3):317-24. PubMed ID: 15939335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of peptide-binding specificity of IAP BIR domains.
    Eckelman BP; Drag M; Snipas SJ; Salvesen GS
    Cell Death Differ; 2008 May; 15(5):920-8. PubMed ID: 18239672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting apoptosis pathways for the treatment of pediatric cancers.
    Fulda S
    Pediatr Blood Cancer; 2009 Oct; 53(4):533-6. PubMed ID: 19148945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.